---
title: "PULIKE's subsidiary has obtained a new veterinary drug registration certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245661416.md"
description: "PULIKE's wholly-owned subsidiary Luoyang Huizhong Biotechnology Co., Ltd. has obtained a new veterinary drug registration certificate, approving a vaccine that can prevent Newcastle disease, infectious bronchitis, infectious bursal disease, and viral arthritis in chickens. This vaccine has advantages such as a long immune protection period, rapid antibody production, and high antibody titers, aimed at reducing losses in the poultry farming industry"
datetime: "2025-06-23T09:11:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245661416.md)
  - [en](https://longbridge.com/en/news/245661416.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245661416.md)
---

# PULIKE's subsidiary has obtained a new veterinary drug registration certificate

According to the announcement from PULIKE (603566.SH), the company has received approval from the Ministry of Agriculture and Rural Affairs for its wholly-owned subsidiary Luoyang Huizhong Biotechnology Co., Ltd. (referred to as "Huizhong Biotechnology") to jointly apply with other units for the "Inactivated Vaccine for Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, and Viral Arthritis (LaSota strain + M41 strain + VP2 protein + AV2311 strain)" as a new veterinary drug. The issuance of the "New Veterinary Drug Registration Certificate" (Announcement No. 920 of the Ministry of Agriculture and Rural Affairs of the People's Republic of China) was publicly announced on June 23, 2025.

This new veterinary drug was jointly applied for by Huizhong Biotechnology and other units, and the Ministry of Agriculture and Rural Affairs announced the issuance of the new veterinary drug registration certificate on June 23, 2025. Newcastle disease, infectious bronchitis, infectious bursal disease, and viral arthritis are among the significant diseases that severely threaten the poultry farming industry, causing substantial losses to the poultry industry. This new veterinary drug is the company's first combined vaccine product that can be used to prevent viral arthritis, featuring advantages such as a long immune protection period, rapid antibody production, high antibody titers, strong protection, reduced stress in flocks, and improved production performance

### Related Stocks

- [603566.CN](https://longbridge.com/en/quote/603566.CN.md)

## Related News & Research

- [01:00 ET"Greatest Tomatoes from Europe" Returns to the USA to Celebrate the Quality, Heritage, and Versatility of European and Italian Canned Tomatoes](https://longbridge.com/en/news/287007471.md)
- [Cotton Falling Back to Start Turnaround Tuesday Trade](https://longbridge.com/en/news/286913130.md)
- [09:20 ETHaier Signs Four-Year Sponsorship with Al Ahly FC, Becoming the Club's Second Main Sponsor](https://longbridge.com/en/news/287073987.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [TECHNICALS-CBOT soybeans may extend gains into $12.13-1/2 to $12.17-1/4 range](https://longbridge.com/en/news/287016093.md)